611 results on '"Lebrun-Frenay, Christine"'
Search Results
2. Rituximab alone is as effective as associated with steroids on naive patients with generalized myasthenia gravis
3. The diagnostic workup of children with the radiologically isolated syndrome differs by age and by sex
4. Dental Adverse Effects of Anti-CD20 Therapies
5. Alexithymia in radiologically isolated syndrome
6. Real-World Effectiveness of Natalizumab Extended Interval Dosing in a French Cohort
7. Radiologically isolated syndrome
8. Sphingosine-1 Phosphate Receptor Modulators Increase In Vitro Melanoma Cell Line Proliferation at Therapeutic Doses Used in Patients with Multiple Sclerosis
9. Towards a more precise rating of neurological disability in multiple sclerosis: A new automatic and linear quantification of limbs function
10. Comparing functional impact of multiple sclerosis on two populations in France, in the Caribbean Sea and in Europe, in regard of care level
11. COPP-MS: COrticosteroids during the Post-Partum in relapsing Multiple Sclerosis patients
12. Effects of socioeconomic status on excess mortality in patients with multiple sclerosis in France: a retrospective observational cohort study
13. Facial emotion impairment in multiple sclerosis is linked to modifying observation strategies of emotional faces
14. From the prodromal stage of multiple sclerosis to disease prevention
15. Disease modifying therapies and disease activity during pregnancy and postpartum in a contemporary cohort of relapsing Multiple Sclerosis patients
16. Reliability of mobile video-oculography in multiple sclerosis patients using an iPad: A prospective validation study
17. Comparison of switching to 6-week dosing of natalizumab versus continuing with 4-week dosing in patients with relapsing-remitting multiple sclerosis (NOVA): a randomised, controlled, open-label, phase 3b trial
18. Long-Term Effectiveness, Safety and Tolerability of Fingolimod in Patients with Multiple Sclerosis in Real-World Treatment Settings in France: The VIRGILE Study
19. Comparative Effectiveness of Natalizumab Versus Anti-CD20 in Highly Active Relapsing–Remitting Multiple Sclerosis After Fingolimod Withdrawal
20. Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone—A Case Report
21. Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion
22. Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference
23. Treatment regimens for neuromyelitis optica spectrum disorder attacks: a retrospective cohort study
24. Validation française et informatisée du questionnaire MSWDQ évaluant les difficultés au travail des patients atteints de sclérose en plaques : résultats de l’étude WORKSEP
25. Kappa Free Light Chain Biomarkers Are Efficient for the Diagnosis of Multiple Sclerosis: A Large Multicenter Cohort Study
26. Neurofilament Light Chain Levels Are Predictive of Clinical Conversion in Radiologically Isolated Syndrome
27. Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability
28. How to switch disease-modifying treatments in multiple sclerosis: Guidelines from the French Multiple Sclerosis Society (SFSEP)
29. Aquaporin 4 distribution in the brain and its relevance for the radiological appearance of neuromyelitis optica spectrum disease
30. Memory B Cells Predict Relapse in Rituximab-Treated Myasthenia Gravis
31. Relapses in Patients Treated with High-Dose Biotin for Progressive Multiple Sclerosis
32. Acute Clinical Events Identified as Relapses With Stable Magnetic Resonance Imaging in Multiple Sclerosis.
33. T2-fluid attenuated inversion recovery fat-suppressed mismatch in the identification and characterization of lesions related to radiologically isolated syndrome.
34. Cancer and multiple sclerosis: 2023 recommendations from the French Multiple Sclerosis Society
35. COVID-19 outcomes in patients with multiple sclerosis: Understanding changes from 2020 to 2022
36. Time to move past typical syndromes in the diagnosis of multiple sclerosis.
37. Effects on Melanoma Cell Lines Suggest No Significant Risk of Melanoma Under Cladribine Treatment
38. Impact of executive dysfunction on naming ability in multiple sclerosis
39. CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseasesʼ Treatments
40. Comparison of 2 Methods for Estimating Multiple Sclerosis–Related Mortality
41. Bevacizumab: Is the lower the better for glioblastoma patients in progression?
42. Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension
43. Complementary and alternative medicine use in glioma patients in France
44. Five-year outcome in the copaxone observatory: a nationwide cohort of patients with multiple sclerosis starting treatment with glatiramer acetate in France
45. The biological sample collection of the OFSEP French MS registry: An essential tool dedicated to researchers
46. Kappa Free Light Chain Index Predicts Disease Course in Clinically and Radiologically Isolated Syndromes
47. Letter to the editor on “new algorithmic approach for easier and faster extended disability status scale calculation”
48. High-Efficacy Therapy Discontinuation vs Continuation in Patients 50 Years and Older With Nonactive MS
49. Risk of autoimmune diseases and human papilloma virus (HPV) vaccines: Six years of case-referent surveillance
50. HMGB1/anti-HMGB1 antibodies define a molecular signature of early stages of HIV-Associated Neurocognitive Disorders (HAND)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.